S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking.

Granulocyte chemotaxis and disease expression are differentially regulated by GRK subtype in an acute inflammatory arthritis model (K/BxN).

Distinct conformational changes in beta-arrestin report biased agonism at seven-transmembrane receptors.

Beta-arrestin scaffolding of phosphatidylinositol 4-phosphate 5-kinase Ialpha promotes agonist-stimulated sequestration of the beta2-adrenergic receptor.

Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor.

Beta-arrestins regulate atherosclerosis and neointimal hyperplasia by controlling smooth muscle cell proliferation and migration.

Beta-arrestin-mediated localization of smoothened to the primary cilium.

The annual ASCI meeting: does nostalgia have a future?

Beta-arrestin-mediated signaling regulates protein synthesis.

A crystal clear view of the beta2-adrenergic receptor.

Crystallizing thinking about the beta2-adrenergic receptor.

A beta-arrestin 2 signaling complex mediates lithium action on behavior.

beta-arrestin-biased agonism at the beta2-adrenergic receptor.

beta2-adrenergic receptor signaling and desensitization elucidated by quantitative modeling of real time cAMP dynamics.

A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling.

Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection.

Ubiquitination of beta-arrestin links seven-transmembrane receptor endocytosis and ERK activation.

Beta-arrestin-biased ligands at seven-transmembrane receptors.

Functional specialization of beta-arrestin interactions revealed by proteomic analysis.

The active conformation of beta-arrestin1: direct evidence for the phosphate sensor in the N-domain and conformational differences in the active states of beta-arrestins1 and -2.